The European Medical Journal ushered in the New Year with a bang with the publication of EMJ Innovations 2.1. This edition is packed with the most exciting upcoming medical innovations and ongoing research.

Last year marked the EADV’s 30th anniversary, and there was no better place to celebrate the momentous event than in its home city of Geneva, Switzerland. Attracting both dermatologists and aesthetic specialists alike, the picturesque landscape of the Alps and Lake Geneva seemed most appropriate for the backdrop of this year’s congress.

Over the years, the study of the pathophysiology and pharmacology of allergen-induced asthma has been based on several allergen inhalation challenge models, which have specific benefits and disadvantages. In this issue of the journal...

Dexamethasone Contributes to the Side Effects in Glioblastoma Treatment.

The General Data Protection Regulation (GDPR) comes into practice on the 25th May, and is a positive step towards you having more control over how your data is used and how you're contacted. Please use the link below to confirm that you are happy to subscribe to our mailing list.